The Role of the GP in the Management of Ambulatory Heart Failure (GPsHF)

Jean-Marc BOIVIN

Status: Enrolling

Conditions: Heart Failure

Study type: Observational

Funder types: Other

Identifiers

NCT05056649

2020PI049

Details and patient eligibility

About

To describe the causes mentioned by general practitioners, explaining the under-treatment of the three main treatments for heart failure with impaired ejection fraction (ARS blockers of the type ACEinhibitor/ARA2/ARNi, ß- and/or anti-aldosterone).

Enrollment: 300 estimated patients

Sex: All

Ages: 18 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Patients with a previous diagnosis of heart failure with impaired ejection fraction (LVEF < 40%)
• Under 85 years of age
• Admitted to an Emergency department for cardiac decompensation
• Hospitalized following this decompensation
• Not deceased within one month of hospitalisation
• Whose sum of the doses of ACEI or ARB2 + BB + aldosterone antagonist is less than 50% of the dose required for this patient* (definition in annex)
• Who did not object within one month of being informed

Exclusion Criteria:- Patient objecting to the use of their data

• Patient who is a minor
• Patient who does not have a general practitioner

Trial design

300 participants in 1 patient group

Heart Failure Patients with impaired ejection fraction